key: cord-0722025-f15foaf2
authors: Foo, Oliver; Hiu, Shaun; Teare, Dawn; Syed, Akheel A.; Razvi, Salman
title: A global country‐level analysis of the relationship between obesity and COVID‐19 cases and mortality
date: 2021-08-25
journal: Diabetes Obes Metab
DOI: 10.1111/dom.14523
sha: fa923468b17ccb78ac6f2291be5b91f5a31ee593
doc_id: 722025
cord_uid: f15foaf2

AIM: To assess the association of country‐level obesity prevalence with COVID‐19 case and mortality rates, to evaluate the impact of obesity prevalence on worldwide variation. METHODS: Data on COVID‐19 prevalence and mortality, country‐specific governmental actions, socioeconomic, demographic, and healthcare capacity factors were extracted from publicly available sources. Multivariable negative binomial regression was used to assess the independent association of obesity with COVID‐19 case and mortality rates. RESULTS: Across 168 countries for which data were available, higher obesity prevalence was associated with increased COVID‐19 mortality and prevalence rates. For every 1% increase in obesity prevalence, the mortality rate was increased by 8.3% (incidence rate ratio [IRR] 1.083, 95% confidence interval [CI] 1.048‐1.119; P < 0.001) and the case rate was higher by 6.6% (IRR 1.066, 95% CI 1.035‐1.099; P < 0.001). Additionally, higher median population age, greater female ratio, higher Human Development Index (HDI), lower population density, and lower hospital bed availability were all significantly associated with higher COVID‐19 mortality rate. In addition, stricter governmental actions, higher HDI and lower mean annual temperature were significantly associated with higher COVID‐19 case rate. CONCLUSION: These findings demonstrate that obesity prevalence is a significant and potentially modifiable risk factor of increased COVID‐19 national caseload and mortality. Future research to study whether weight loss improves COVID‐19 outcomes is urgently required.

prevention policies to restrict the spread of the virus, impacting the physical and mental well-being of individuals as well as devastating economies globally. The estimated world output in gross domestic product (GDP) for 2020 was À3.5%, with the UK being amongst the worst affected countries, having an estimated drop in GDP of À10.0%. 4 With the attainment of herd immunity being considered an exit strategy, a worldwide vaccination initiative on an unprecedented scale is being implemented. Early data are promising, with one study showing a single dose reduces hospitalization and COVID-19-related mortality by 80% and 85%, respectively. 5 However, there is increasing recognition that vaccination alone will not eradicate COVID-19. As SARS-CoV-2 continues to evolve, new variants are emerging with the potential of escaping vaccine-mediated immunity, posing the risk of recurring outbreaks. This has forced societies to accept a new and uncertain future as governments and individuals will likely need to uphold containment and prevention measures as a long-term reality, adopting behaviours such as mask wearing, social distancing and hand hygiene as part of the new normal, whilst returning to sustainable social and economic activities. 6, 7 Thus, identifying risk factors to predict individuals at high risk of contracting and developing serious illness from the disease are crucial to prevent further loss of life and reduce economic and healthcare burden.

COVID-19-related prevalence and mortality rates vary significantly among countries. 1 increased COVID-19 burden. 1, [8] [9] [10] [11] [12] [13] [14] [15] [16] Increasingly, obesity has been associated with both COVID-19 severity and mortality. 11, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Similar associations have been observed with other respiratory illnesses such as seasonal influenza, H1N1 and Middle East respiratory syndrome, as those with obesity are disproportionately at risk of hospitalization and mortality. 23, [27] [28] [29] However, the extent to which obesity prevalence independently contributes to country-level case and mortality rates is uncertain. A country-level exploratory analysis found that obesity was associated with increased caseloads and mortality. 15 However that study was limited to 50 countries with the highest caseloads, analysed outcome data only for a few months after the start of the pandemic (up to May 1, 2020), and did not consider additional factors that may have an impact on COVID-19 outcomes. A different study used a multivariable regression model to assess the association of obesity with COVID-19 mortality rate at the country level; however, there was no analysis of COVID-19 case rate with obesity and only 30 industrialized countries were included in the model. 30 Thus, the aim of this analysis was to evaluate the extent to which obesity prevalence contributes to the variation in COVID-19 worldwide, by performing a country-level observational analysis assessing country-specific COVID-19 case and mortality rates in relation to country-specific obesity prevalence rates, whilst accounting for other potential confounding factors. Data collected included characteristics on demographics of countries. OWD and the World Population Review were used to extract data on median population age, an indicator of age structure. 37, 38 Gender ratio was recorded as the female population proportion (%), with data collected from OWD and NationMaster. 39, 40 Data on population density, recorded as the number of people per km 2 of land area, were taken from the World Bank (WB) and World Population Review. 41, 42 Alongside population density, urban population (%) was also recorded as urban areas have emerged as epicentres of the pandemic, with data collected from OWD and the United Nations. [43] [44] [45] Several social, economic and political variables were also included as potential confounding factors. Human development was measured using the Human Development Index (HDI), obtained from OWD, which assesses three key dimensions of human development, scaled from 0 to 1 (1 = most developed): a long and healthy life measured by life expectancy at birth; access to knowledge of younger and older generations, respectively, measured by the expected and average years of schooling; and a decent standard of living, measured by gross national income per capita. 46 Democracy was measured using a scale for political regime ranging from À10 (full autocracy) to +10 (full democracy), taken from OWD. 47 Data on healthcare capacity and the strain on healthcare regarding lifestyle and comorbidity factors, including the number of hospital beds per 1000 population and daily tobacco smoking prevalence rates (%), were collected from the WB and OWD, respectively. 50, 51 The total burden of cardiovascular, respiratory, cancer and endocrine diseases was measured using disability-adjusted life-years (DALYs) lost (millions) from OWD. DALYs were the chosen metric as prevalence rates were not recorded at the population level for all four groups of diseases. 52 Furthermore, data regarding a number of additional factors that have been previously hypothesized to influence the transmission, infectivity and severity of COVID-19 were further collected. 53-58 Data on Bacillus Calmette-Guérin (BCG) vaccination coverage were extracted from the WHO and measured as the proportion of 1-yearolds vaccinated with BCG (%). 59 Temperature was measured as the mean annual temperature from 1901 to 2016 ( C), obtained from the WB. 60 Finally, OWD provided data on air pollution, measured as the mean annual exposure (μg/m 3 ) to particulate matter ≤2.5 μg (PM 2.5 ). 61 

The outcome variables of interest were the rates of COVID-19-related mortalities and COVID-19 cases (expressed per million population). As mortality rate is an indicator of more severe disease and is less likely to be influenced by factors such as COVID-19 testing and containment and health policies, this was identified as the primary outcome of interest. The unit of analysis was each individual country. A univariate analysis was first performed to examine an association between outcome and obesity prevalence. Scatter graphs were plotted with a regression line and Spearman ρ was calculated to assess any significant correlation (defined as P ≤ 0.01). However, a range of confounding variables are known to influence COVID-19 infection and mortality rates, thus a multivariable analysis was conducted to assess the independent association of obesity prevalence with COVID-19 case and mortality rates.

Poisson regression is typically used to assess count data. However, overdispersion (when the conditional variance exceeds the conditional mean) was predicted with the country-level nature of the dataset, thus precluding it as an appropriate model. Multivariable negative binomial regression accounts for overdispersion and was therefore used as a more appropriate model. (e) democracy scale; (f) GDP per capita; (g) mean annual air pollution;

and (h) DALYs lost to cardiovascular, cancer, respiratory and endocrine diseases (a total of eight additional models). These variables were not included in the primary model due to concerns over model overfitting. Furthermore, the relationships between these variables and the dependent outcomes are still unclear and therefore these analyses are exploratory.The goodness of fit of the primary model compared to secondary models was assessed by Akaike's information criterion, whereby lower values of the index indicate the preferred model. 62 The statistical significance of the model was assessed with an Omnibus test. Statistical significance was defined as P < 0.05 and confidence intervals (CIs) were set at 95%. All outcomes of the regression analysis were reported as exponential β coefficients (referred to as incidence rate ratio [IRR]), whereby a value less than one suggests a decreased likelihood and a value greater than one suggests an increased likelihood of the outcome. All data were analysed using IBM SPSS Statistics (version 27), Chicago, Illinois. Predictive graphs were generated using Stata/SE (version 16), College Station, Texas.

The characteristics of 168 countries, for which complete data regarding COVID-19, demographics, socioeconomic and health-related factors were available, are summarized in Table 1 (Table 2) . Obesity prevalence was positively, significantly and independently associated with COVID-19 mortality rate (Table 3) . For every 1% increase in obesity prevalence, the mortality rate was higher by 8.3% (IRR 1.08, 95% CI 1.05-1.12; P < 0.001; Figure 1 ). Other variables that significantly predicted COVID-19 mortality rate were median age (every 1-year increase in median age associated with a 5.7% higher mortality rate), gender ratio (every 1% increase in female population increasing the mortality rate T A B L E 2 Available data for the countries excluded from the primary analysis due to an incomplete multivariate dataset (n = 28) Across the 168 countries with a complete multivariate dataset, obesity prevalence was positively, significantly and independently associated with COVID-19 case rate (Table 4 ). For every 1% increase in obesity prevalence, the case rate was higher by 6.6% (IRR 1.07, 95% CI 1.04-1.10; P < 0.001). Thus, as obesity prevalence increases, the predicted case rate is higher (Figure 2 ). Other variables that significantly predicted COVID-19 case rate were the CHI (every one-unit increase raising the case rate by 2.6%) and the HDI (every one-unit- 65 There have also been some reports of insignifi- This is particularly important in the treatment of COVID-19 patients with obesity as they demonstrate an increased susceptibility to developing ARDS compared to lean adults. 67 However, prone-positioning requires regular turning of the sedated individual, which can prove physically demanding for ICU staff treating those with obesity. 17 Being an individual with obesity is also associated with dysregulation of the immune system, potentially having adverse effects upon infection with SARS-CoV-2. Adipose tissue is a recognized endocrine organ that secretes adipokines, cytokines and chemokines which maintain a balanced pro-and anti-inflammatory environment. However, obesity significantly alters the profile of immune cells and offsets this balance.

An increase in proinflammatory cells, such as CD8+ T cells and M1

F I G U R E 2 The relationship between predicted COVID-19 case rate with obesity prevalence. Error bars show 95% confidence intervals. The predicted COVID-19 case rate associated with obesity prevalence is independent of other factors included in the primary model macrophages, with the consequent release of proinflammatory cytokines such as interleukin-6 and C-reactive protein, induces a state of low-grade chronic inflammation which is characteristic of obesity.

Recent studies have linked COVID-19 severity with a dysregulation of proinflammatory cytokines. Therefore, acute inflammation from COVID-19 may exacerbate the underlying state of chronic inflammation, which can ultimately trigger a hyper-inflammatory response. 17, 20, 68 This is consistent with a study that identifies lowgrade inflammation as a risk factor for severe COVID-19, suggesting it partly explains the high hospitalization rate amongst those with obesity. 69 Obesity in an individual is also associated with a range of addi- postulates that the "hygiene hypothesis" may partly explain this observation, suggesting that low socioeconomic countries with poorer hygiene may train a more robust innate immune system during childhood due to frequent exposure to environmental microbes, ultimately minimizing the susceptibility and severity to COVID-19. 74 Older age was identified as an independent predictor of COVID-19 mortality, which is consistent with an extensive range of studies that identify age as a risk factor for COVID-19 severity. 1, 8, 10, 11, 19, 71, 75, 76 Similarly, greater hospital bed availability was shown to independently predict a lower COVID-19 mortality rate, which is unsurprising as increased healthcare capacity would allow countries to treat surges in COVID-19 cases more effectively. 14 An unexpected finding was that the proportion of females in a population was positively associated with COVID-19 mortality rate, contradicting the majority of the available literature which implicate male sex as a risk factor for COVID-19

severity. 8, 10, 12, 19, 64, 69 This may reflect global variations in socioeconomic and work-related factors amongst the sexes, or it may have arisen from using two sources to complete data collection, which could have impeded the accuracy of the dataset. However, in support of our findings one study showed that a higher BMI was associated with a stronger risk of COVID-19 mortality in women than men. 77 The association of sex with COVID-19 mortality requires further investigation. Interestingly, smoking prevalence was not significantly associated with COVID-19 prevalence or mortality. The available literature suggests that the effect of daily smoking on COVID-19 is controversial; however, the majority of studies suggest smoking is positively associated with COVID-19 severity. 78 The findings of this study strengthen evidence for an independent association of obesity with increased COVID-19 prevalence and mortality rates worldwide. This has important implications for those with obesity, as well as for healthcare professionals and policy makers. Further research is required to better understand the cellular and molecular mechanisms that predispose those with obesity to increased risk of Public health interventions, such as weight loss initiatives, may be critical in reducing the level of obesity in the general population, however, this will require concerted and sustained efforts by governments, industry and society. This will help improve resilience and reduce the burden on individuals, as well as on healthcare systems and the economy in future pandemics.

In conclusion, the findings of this study demonstrate that obesity is a significant and independent predictor of COVID-19 prevalence and mortality. This is the first study to assess the statistical and independent association of obesity with COVID-19 case and mortality rates on a global scale.

The authors declare that there is no conflict of interest.

Oliver Foo: This author helped design the study, collect the data, perform the data analysis, interpret the data and write the manuscript. 

The peer review history for this article is available at https://publons. com/publon/10.1111/dom.14523.

The authors declare that the data collected for the study was gathered from publicly available databases. All sources have been stated in the list of references and thus are available to others. This data includes country-level characteristics which were used in the statistical analysis.

ORCID Oliver Foo https://orcid.org/0000-0001-5488-6220

Akheel A. Syed https://orcid.org/0000-0001-8696-7121

Salman Razvi https://orcid.org/0000-0002-9047-1556

Explaining among-country variation in COVID-19 case fatality rate

The World Health Organisation. WHO Coronavirus Disease (COVID-19) Dashboard

Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)

World Economic Outlook

Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, Hospitalisations and mortality in older adults in the UK: a test negative case control study

Future scenarios for the COVID-19 pandemic

From the "new Normal" to a "new future": a sustainable response to COVID-19

Factors influencing global variations in COVID-19 cases and fatalities; a review

Population risk factors for COVID-19 mortality in 93 countries

COVID-19 case-fatality rate and demographic and socioeconomic influencers: worldwide spatial regression analysis based on country-level data

Risk factors for severe and critically ill COVID-19 patients: a review

Gender differences in patients with COVID-19: focus on severity and mortality

Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission

Coronavirus disease 2019 (COVID-19): a modeling study of factors driving variation in case fatality rate by country

A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes

The relationship between cultural tightness-looseness and COVID-19 cases and deaths: a global analysis

Obesity: a critical risk factor in the COVID-19 pandemic

Impact of obesity on COVID-19 patients

Obesity and mortality among patients diagnosed with COVID-19: results from an integrated health care organization

Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships

Obesity in patients with COVID-19: a systematic review and meta-analysis

Obesity is associated with increased severity of disease in COVID-19 pneumonia: a systematic review and meta-analysis

Obesity increases the severity and mortality of influenza and COVID-19: a systematic review and meta-analysis

The Association of Obesity, type 2 diabetes, and hypertension with severe coronavirus disease 2019 on admission among Mexican patients

Obesity and COVID-19 severity in a designated Hospital in Shenzhen

Obesity and mortality among patients diagnosed with COVID-19: a systematic review and meta-analysis

Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

Obesity is associated with higher risk of intensive care unit admission and death in influenza a (H1N1) patients: a systematic review and meta-analysis

Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis

Obesity as a driver of international differences in COVID-19 death rates

The World Health Organisation. Prevalence of Obesity Among Adults, BMI ≥ 30, Age-Standardized Estimates by Country

Global Obesity Levels

Prevalence of Adult Overweight and Obesity (%)

The World Health Organisation

COVID-19) Testing 2020

Policy Responses to the Coronavirus Pandemic

Age Structure

Total Population: Countries Compared

The World Bank Data

World Population Review. Countries by Density

Policy Brief: COVID-19 in an Urban World

Association of Country-wide Coronavirus Mortality with demographics, testing, lockdowns, and public wearing of masks

Human Development Index (HDI) 2014. https:// ourworldindata.org/human-development-index

International Monetary Fund. GDP per Capita, Current Prices

The World Bank. GDP per Capita (Current US$)

Hospital beds (per 1,000 people)

Burden of Disease

BCG vaccination and mortality of COVID-19 across 173 countries: an ecological study

BCG vaccine Rrotection from severe coronavirus disease 2019 (COVID-19)

Air pollution and temperature are associated with increased COVID-19 incidence: a time series study

Air transportation, population density and temperature predict the spread of COVID-19 in Brazil

Effects of temperature and humidity on the daily new cases and new deaths of COVID-19 in 166 countries

Air pollution and Covid-19: the role of particulate matter in the spread and increase of Covid-19's morbidity and mortality

The World Health Organisation. BCG Immunization Coverage Estimates by Country

Climate Change Knowledge Portal 2021

Outdoor Air Pollution 2019. https:// ourworldindata.org/outdoor-air-pollution

Medical Statistics from A to Z: A Guide for Clinicians and Medical Students

Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UKbiobank prospective cohort study

Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of general practitioners research and surveillance Centre primary care network: a cross-sectional study

Associations between Body-Mass Index and COVID-19 severity in 6.9 million people in England: a prospective, community-based, Cohort Study

The potential impacts of obesity on COVID-19

Body mass index is associated with the development of acute respiratory distress syndrome

Obesity and COVID-19: what makes obese host so vulnerable? Immun Age

Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: a communitybased cohort study of 387,109 adults in UK

Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis

Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a Nationwide cohort

Risk factors for positive and negative COVID-19 tests: a cautious and in-depth analysis of UKbiobank data

Obesity -a risk factor for increased COVID-19 prevalence, severity and lethality (review)

Does the hygiene hypothesis apply to COVID-19 susceptibility? Microbes Infect

Risk factors of severe cases with COVID-19: a meta-analysis

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Obesity as a risk factor for COVID-19 mortality in women and men in the UKbiobank: comparisons with influenza/pneumonia and coronary heart disease

Smoking and COVID-19: adding fuel to the flame

Current smoking and COVID-19 risk: results from a population symptom app in over 2.4 million people

The impact of COPD and smoking history on the severity of COVID-19: a systemic review and metaanalysis

Prevalence, severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis

Impact of lockdown on COVID-19 prevalence and mortality during 2020 pandemic: observational analysis of 27 countries

Evaluation of the potential incidence of COVID-19 and effectiveness of containment measures in Spain: a data-driven approach

COVID-19 mortality rates in the European Union, Switzerland, and the UK: effect of timeliness, lockdown rigidity, and population density

Impact of population density on COVID-19 infected and mortality rate in India

Population density, a factor in the spread of COVID-19 in Algeria: statistic study

Impact of temperature and relative humidity on the transmission of COVID-19: a Modelling study in China and the United States

Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis

Diabetes, obesity and COVID-19: a complex interplay

A global country-level analysis of the relationship between obesity and COVID-19 cases and mortality